Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Diaverum and BIOIATRIKI Healthcare Group Form Strategic Partnership to Enhance Renal Care in Greece

Dec 18, 2024•over 1 year ago

Contract Type

partnership

BalochistanHealth Care

Description

Diaverum has expanded its presence in Greece by entering into a ten-year strategic partnership with BIOIATRIKI Healthcare Group, a renowned leader in private healthcare services in Greece and the wider Mediterranean region. The partnership aims to implement Diaverum’s Care Delivery Model, supported by industry-leading technologies and an AI digital suite at Bioclinic Athens and Bioclinic Thessaloniki, to enhance the quality of life for renal care patients.

Company Information

Company

Diaverum

Location

Balochistan, Pakistan

About

Diaverum is a leading global renal care service provider that was acquired by M42 in April 2023. The acquisition made M42 the largest healthcare company in the Middle East and expanded its presence to 26 countries across Europe, Asia, South America and the Middle East. The deal enabled the introduction of healthcare services and healthtech solutions in new markets while enhancing M42’s renal care offerings in the GCC.

Predictive Intelligence
Strategic

ML-powered predictions for Diaverum's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.